Company

IMMIOS b.v.

Biotechnology Research Nl 18 employees

Employees: 18
Contacts: 2
Emails: 2
Phones: 2

www.immios-biotech.com LinkedIn

IMMIOS b.v. Overview

Headquarters: Nl
Website: www.immios-biotech.com
Industry: Biotechnology Research
Employees: 18
Founded: 2022
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

About IMMIOS b.v.

IIMMIOS is a pre-clinical stage company developing IMS-2407 antibody to reset tissue auto-immune disease providing durable relapse-free benefit to patients suffering from auto-immune and inflammatory disease. Our lead program is set-up to file IND/CTA YE 2026 and deliver proof of mechanism in patients (in two indications) in 2028. Portfolio development is ongoing to identify second program following IMS-2407. #autoimmune disease #antibody development #Series A fundraise #immune reset

IMMIOS b.v. Contact Details

People in AeroLeads: 4
With contact data: 2
Email contacts: 2; 50.0% coverage
Phone contacts: 2; 50.0% coverage

IMMIOS b.v. Org Chart

Sample employees and titles

Name	Title	Location	Contact
Sanne Spijkers	Associate Scientist En Lab Management	Eindhoven, North Brabant, Netherlands	Email Phone
Maurice Habraken	Senior Research Associate @ Immios B.v.		View
Hans Van Eenennaam	Biotech Executive	Velp, Gelderland, Netherlands	Email Phone
Sanne (F.s.) Van De Bovenkamp	Scientist at Immios	Gorinchem, South Holland, Netherlands	View